Schedule 13G
ELAN Schedule 13G filing by T. Rowe Price Investment Management
T. Rowe Price Investment Management reported beneficial ownership of 31.5M shares, representing 12% of ELANCO ANIMAL HEALTH INC in this filing.
FiledNov 14, 2025
Ownership dateSep 30, 2025
Reported shares31.5M
Reported ownership12%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
31.5M
Shared voting power
31.5M
Sole dispositive power
31.5M
Shared dispositive power
31.5M
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$21.09as of Nov 14, 2025
Latest tracked price$25.60as of Aug 4, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- T. Rowe Price Investment Management
- CIK
- CIK0001897612
- Accession
- 0001897612-25-000541
- Form
- Schedule 13G
Read the filing in context